Organized by
in collaboration with
under the auspices of
2023 logo AIOM con scritta

Coming soon

November 29th - December 30th, 2023


Paolo A. Ascierto

Director of Department of Melanoma, Cancer Immunotherapy and Development Therapeutics, National Cancer Institute, IRCCS “Fondazione G. Pascale”, Naples, Italy

Antonio Avallone

Unit of Abdominal Medical Oncology, National Cancer Institute “Fondazione G. Pascale”, Naples, Italy

Michele Bartoletti

Medical Oncologist, Department of Clinical Oncology, OMP – IRCCS CRO Aviano National Cancer Institute, Aviano, Italy

Allison Betof Warner

Assistant Professor of Medicine (Oncology), Director, Melanoma Medical Oncology Program, Director, Solid Tumor Cellular Therapy Leader, Melanoma & Cutaneous Oncology Clinical Research Group, Stanford University School of Medicine, Stanford Cancer Center, Stanford, CA, US

 Carlo Bifulco

Chief Medical Officer, Providence Genomics, Director of Translational Molecular Pathology, Earle A. Chiles Research Institute, Providence Cancer Institute, Portland, OR, US

Christian Blank

Medical Oncology and Research Group Leader Tumor Immunology, Netherlands Cancer Institute, Amsterdam; Medical Oncology, Leiden University Medical Center (LUMC), Leiden, Netherlands

Renier Brentjens

Deputy Director & Chair, Department of Medicine, Roswell Park Comprehensive Cancer Center, Buffalo, NY, US

Joshua Brody

Director, Lymphoma Immunotherapy Program, Hess Center for Science and Medicine, Icahn School of Medicine at Mount Sinai, New York, NY, US

Vincenzo Bronte

Scientific Director of the IRCCS Istituto Oncologico Veneto (IOV), Padua, Italy

Tullia Bruno

Assistant Professor Researcher, UPMC Hillman Cancer Center, Pittsburgh, PA, US

Alfredo Budillon

Scientific Director, National Cancer Institute, IRCCS Fondazione “G. Pascale”, Naples, Italy

Luigi Buonaguro

Director Innovative Immunological Models Unit, National Cancer Institute, IRCCS Fondazione “G. Pascale”, Naples, Italy

Elizabeth M. Burton

Executive Director, Translational Research Initiative Development, Genomic Medicine, The University of Texas MD Anderson Cancer Center, Houston, Texas, US

Tina Cascone

Assistant Professor, Department of Thoracic/Head and Neck Medical Oncology, Division of Cancer Medicine, The University of Texas MD Anderson Cancer Center, Houston, TX, US

Myriam Chalabi

Medical Oncologist, GI cancers, Netherlands Cancer Institute, Amsterdam, Netherlands

Sandra Demaria

Professor of Pathology and Laboratory Medicine, Professor of Radiation Oncology, Weill Cornell Medical College, New York, NY, US

Julie Stein Deutsch

Assistant Professor of Dermatology and Pathology, Division of Dermatopathology, Dept. of Dermatology

Johns Hopkins University, Baltimora, MD, USA

Leisha A. Emens

Professor of Medicine, Director of Translational Immunotherapy for the Women’s Cancer Research Center, Co-Leader, Hillman Cancer Immunology/Immunotherapy Program, UPMC Hillman Cancer Center/Magee Women’s Hospital, Pittsburgh, PA, US

 Piera Federico

Medical executive at the Oncology Division, “Ospedale del Mare” Hospital, Naples, Italy

Robert L. Ferris

Director, UPMC Hillman Cancer Center, Professor of Oncology, Associate Vice Chancellor for Cancer Research Center, Professor of Otolaryngology, of Immunology, and of Radiation Oncology, University Pittsburgh School of Medicine, PA, US

Silvia Chiara Formenti

Chairman of the Department of Radiation Oncology, Weill Cornell Medicine; Associate Director of the Meyer Cancer Center, Radiation Oncologist in Chief, New York-Presbyterian Hospital, New York, NY, US

Jerome Galon

Research Director, National Institute of Health and Medical Research (INSERM), Director, Integrative Cancer Immunology Team, Cordeliers Research Center, Paris, France

Neil D. Gross

Professor and Director of Clinical Research, Department of Head and Neck Surgery, Division of Surgery, The University of Texas MD Anderson Cancer Center, Houston, TX, US

James Gulley

Co-Director, Center for Immuno-Oncology, Center for Cancer Research, National Cancer Institute, National Institutes of Health, Bethesda, MD

Clinical Director, National Cancer Institute, National Institutes of Health, Bethesda, MD

 Omid Hamid

Chief of Research/ Immuno-Oncology, Co-Director, Cutaneous Malignancy Program, The Angeles Clinic and Research Institute, a Cedars Sinai Affiliate, Los Angeles, CA, US

Roberto Iacovelli

Clinical specialist, Policlinico Universitario Agostino Gemelli IRCCS, Roma, Italy

Pawel Kalinski

SVP, Team Science; Chair, Department of Immunology; Professor of Oncology & Chief, Translational Immuno-Oncology, Roswell Park Comprehensive Cancer Center, Buffalo, New York, US

Tomas Kirchhoff

Associate Professor, Department of Population Health, Perlmutter Cancer Center, NYU Grossman School of Medicine, New York, NY, US

Rom Leidner

Co-Medical Director Head & Neck Cancer, Earle A. Chiles Research Institute, Providence Cancer Institute, Portland, Oregon, US

Gregory B. Lesinski

Professor, Vice Chair for Basic Research, Department of Hematology & Medical Oncology, Associate Director for Basic Research, Co-Director, Translational GI Malignancy Program, Winship Cancer Institute of Emory University, Atlanta, GA, US

Georgina Long

Co-medical Director , Chair of Melanoma Medical Oncology and Translational Research presso MIA e Royal North Shore Hospital, Melanoma Institute Australia, The University of Sydney, Wollstonecraft

NSW, Australia

Marcela V. Maus

Associate Professor of Medicine, Harvard Medical School; Director of Cellular Immunotherapy, Cancer Center, Massachusetts General Hospital, Boston, MA, US

Alessandro Morabito

Director of Thoracic Medical Oncology, National Cancer Institute, IRRCS “Fondazione G. Pascale”, Naples, Italy

Paul Nathan

Consultant Medical Oncologist, Mount Vernon Cancer Centre Honorary Professor of Oncology UCL

Honorary Consultant Medical Oncologist UCLH, Mount Vernon Cancer Centre UCL – University

College Of London, London, UK

Bart Neyns

Head of Department Medical Oncology, Universitair Ziekenhuis (UZ) Brussel; Clinical Professor at the Faculty of Medicine and Pharmacy, Vrije Universiteit Brussel (VUB), Brussels, Belgium

Kunle Odunsi

Director, University of Chicago Medicine Comprehensive Cancer Center; Dean for Oncology, Biological Sciences Division, The University of Chicago, Chicago, IL, US

Akash Patnaik

Director, Laboratory for Prostate Cancer Developmental Therapeutics/ImmunoOncology Attending Physician, Genitourinary Oncology Program University of Chicago Comprehensive Cancer Center Chicago, IL, US

Chrystal M. Paulos

Associate Professor, Department of Surgery / Microbiology & Immunology, Director of Translational Research, Cutaneous Malignancies, Winship Cancer Institute at Emory University Atlanta, GA, US

Cristina Puig-Saus

Assistant Professor, University of California, Los Angeles (UCLA), Los Angeles, CA, US

Igor Puzanov

Senior Vice President, Clinical Investigation; Professor of Oncology and Medicine, Director of Center for Early Phase Clinical Trials Division, Chief, Melanoma Section, Department of Medicine, Roswell Park Comprehensive Cancer Center, Buffalo, NY, US

Marco Ruella

Assistant Professor of Medicine, Department of Medicine, Perelman School of Medicine, University of Pennsylvania, Philadelphia, PA, US

Stephen Schoenberger

Professor, La Jolla Institute for Immunology, Adjunct Prof. UCSD Moores Cancer Center, Director of Translational Science, San Diego Center for Precision Immunotherapy, La Jolla Institute for Immunology, San Diego, CA, USA

Brahm Segal

Chair, Department of Internal Medicine, Chief, Division of Infectious Diseases, Professor of Oncology, Member, Department of Immunology, Roswell Park Comprehensive Cancer Center; Professor of Medicine, Jacobs School of Medicine and Biomedical Sciences, University at Buffalo, Buffalo, NY, US

Janis Taube

Director, Division of Dermatopathology, Professor of Dermatology, Johns Hopkins University, School of

Medicine, Baltimore, MD, US

Sofie Wilgenhof

Medical oncologist and IO specialist, Antoni van Leeuwenhoek Hospital, Amsterdam, The Netherlands